How Long Does CJC-1295 Ipamorelin Stay in Your System?

One question, three correct answers. Which one applies depends on a single structural detail: whether the CJC-1295 in the vial carries the Drug Affinity Complex, usually shortened to DAC. Ipamorelin clears in hours. CJC-1295 without DAC clears faster still. The DAC-modified version circulates for days, because it is chemically bolted to albumin.

Our team supplies research-grade peptides to laboratories, and how long does CJC-1295 Ipamorelin stay in your system is the pharmacokinetics question we field most often. One clarification before anything else: everything below describes clearance as the research literature reports it. These are research-use-only compounds, not approved drugs, and not for human or veterinary use.

How long does CJC-1295 Ipamorelin stay in your system?

Ipamorelin and CJC-1295 without DAC are short-acting, with persistence the literature describes in hours or less, so functional clearance falls inside roughly a day. CJC-1295 with DAC binds serum albumin and persists on the order of days, pushing near-complete clearance out to two or three weeks. Blend composition decides the answer.

The usual oversimplification is treating CJC-1295 as one compound. It isn't. Most material sold as a CJC-1295 and Ipamorelin blend is the no-DAC form, structurally closer to modified GRF (1-29), which is why forum half-life figures for the same product name disagree by a factor of a hundred. This brief covers the structural basis of each half-life, the clearance arithmetic that turns a half-life into a timeline, why the IGF-1 signature outlasts both peptides, and what actually determines how long a vial of CJC-1295 Ipamorelin lasts on the bench.

Two peptides, three clearance timelines

A blend vial holds two different molecules with two different exit routes, and the CJC-1295 component exists in two forms whose persistence differs by orders of magnitude.

Ipamorelin is a pentapeptide that acts as a selective agonist at the growth hormone secretagogue receptor (GHS-R1a), the same receptor ghrelin binds. It has no albumin-binding modification and is broken down enzymatically, so the literature describes its elimination half-life as short, on the order of a couple of hours rather than days. We are deliberately not quoting a decimal figure. Reported values differ by assay and species, and we will not attach precision to a number we cannot point to in a specific indexed paper.

CJC-1295 without DAC is a tetrasubstituted analogue of GHRH (1-29), the bioactive fragment of growth hormone releasing hormone. Its substitutions, including D-alanine at position two, blunt cleavage by dipeptidyl peptidase-IV (DPP-IV), the enzyme that degrades native GHRH within minutes. That buys durability relative to the native hormone, not a long half-life. Published estimates for the no-DAC form sit under an hour and do not converge on one value.

CJC-1295 with DAC adds a maleimidopropionic acid linker that forms a covalent bond with cysteine-34 on circulating serum albumin. Albumin turnover is measured in weeks, so the bound peptide inherits a circulating half-life the literature describes on the order of days.

From half-life to full clearance: the five-half-life rule

First-order elimination does the work here. After five half-lives, roughly 97% of a compound has been eliminated; after seven, more than 99%. That arithmetic, not vendor copy, is what converts a half-life into a clearance timeline.

Run it through each component. An Ipamorelin half-life measured in a small number of hours puts functional clearance comfortably inside 24 hours. For the no-DAC analogue, the answer to how long does CJC-1295 Ipamorelin no DAC stay in your system is shorter still: with reported half-lives under an hour, the parent peptide is effectively gone within the same working day. A DAC-modified half-life on the order of days stretches the same calculation to roughly two to three weeks for near-complete clearance.

So when someone asks how long does CJC-1295 and Ipamorelin stay in your system, the honest response is that the Ipamorelin side of the answer is stable across products, and the CJC-1295 side swings by a factor of fifty depending on DAC status. Our team routinely gets this question from labs holding a vial whose label says only CJC-1295, with no DAC designation anywhere on it.

One caveat that matters more than the numbers: plasma clearance of a secretagogue is not the same as the end of its downstream effect. The molecule leaving circulation is the start of the story, not the finish.

Why the biological signature outlasts the molecule

The peptide can be analytically undetectable while the endocrine change it triggered is still clearly measurable. That gap is the most common design error we see discussed in growth hormone secretagogue research.

Here is the mechanism. Both compounds work indirectly: Ipamorelin through GHS-R1a and CJC-1295 through the GHRH receptor, both converging on pituitary somatotrophs to increase growth hormone release. Growth hormone then drives hepatic production of IGF-1 (insulin-like growth factor 1). IGF-1 does not circulate free. It travels almost entirely bound to IGFBP-3 and the acid-labile subunit in a ternary complex that shields it from renal clearance and extends its residence far beyond that of the secretagogue that caused it.

The mistake most guides make is not the half-life figure. It is the assumption that clearance of the parent peptide equals a return to baseline. Baseline in this system is a pulse architecture, meaning growth hormone pulse amplitude and frequency, and it does not necessarily normalise on the parent compound's timetable. A washout window calculated from the peptide's half-life alone can carry endocrine carryover straight into the next arm of a crossover design.

Detection follows the same logic. An analytical window depends on assay sensitivity, whether the target is the intact peptide by LC-MS/MS or a biomarker panel built on growth hormone and IGF-1. Anti-doping context is worth knowing: the World Anti-Doping Agency prohibits GHRH analogues and growth hormone secretagogues at all times under class S2 of its Prohibited List, and biomarker-led approaches can outlast the compound itself.

How long a vial of CJC-1295 Ipamorelin lasts in the lab

Two separate questions hide inside this one, and we only answer the second. How many administrations a vial covers is a dosing question. Real Peptides does not provide dosing, timing, or preparation guidance, because these are research-use-only compounds and that guidance is not ours to give. Material stability we can talk about plainly.

Lyophilised powder is the stable format, which is why peptides ship that way. Held cold, dry, and protected from light, the freeze-dried form is built for extended storage. In aqueous solution the picture changes: hydrolysis, oxidation of susceptible residues, and repeated freeze-thaw cycles all degrade peptide material, so laboratories generally keep solutions refrigerated, shielded from light, and free of temperature excursions. Clarity tells you very little. Degradation is an analytical finding, not a visual one, and a solution that looks perfect can have lost potency.

On quantity, the only measurement education appropriate here is concentration. A certificate of analysis states the total peptide mass in the vial, so a 5mg/5mg blend contains 5mg of each component, and concentration in mg per mL is simply total milligrams divided by the volume of solution. That is where the arithmetic stops. Before procurement, verifying the CAS number and molecular identity on the certificate against the compound you intend to study is the single cheapest quality control step available. Nothing in this brief is medical, dosing, or administration guidance.

CJC-1295 with DAC, without DAC and Ipamorelin: clearance side by side

The table below sets the three components against each other on structure, reported persistence, and the clearance window that structure implies. It matters because the same product name can describe compounds at either end of this range.

What If: Clearance and Vial Scenarios

What if the vial label just says CJC-1295 with no DAC status?

Treat DAC status as unknown and resolve it from the certificate of analysis and molecular identity before assuming any half-life. The two forms differ in molecular weight and sequence modification, so the certificate settles it where the label doesn't. Without that confirmation, a clearance estimate could be wrong by a factor of fifty, which is the difference between a same-day washout and a three-week one. Verifying the compound against a publicly available certificate takes minutes and removes the guesswork entirely.

What if a study design switches between the DAC and no-DAC analogue?

Build the washout from the longer-acting compound and from the biomarker, not from the shorter peptide. With a DAC half-life on the order of days, five half-lives already spans weeks, and IGF-1 in its ternary complex can stay elevated after the peptide has cleared. Designs that measure IGF-1 or growth hormone pulse parameters before the next arm begins catch carryover that arithmetic alone misses. The literature does not specify a single universal washout interval, which is precisely why the biomarker check exists.

What if the question is really about morning versus night timing?

We do not provide administration timing for people, because these are research-use-only compounds and timing guidance would be dosing advice. What the literature does describe is relevant: endogenous growth hormone secretion is pulsatile and its largest pulses occur during slow-wave sleep, and the somatotroph response to a GHRH analogue is modulated by somatostatin tone, circulating glucose, and free fatty acids. That is why published studies report administration conditions such as fasted state and time of day as controlled variables rather than as free choices.

What if material has been held in solution longer than intended?

Treat potency as unknown rather than reduced by some assumed percentage. Peptides in aqueous solution are subject to hydrolysis and oxidation, and freeze-thaw cycling accelerates loss, none of which changes how the solution looks. A clear vial is not evidence of an intact molecule. The only way to know what remains is analytical testing, and for quantitative work, unresolved uncertainty in the input concentration undermines every result downstream of it.

The blunt truth about the half-life numbers you will find online

Let's be direct about this: most half-life figures circulating for this blend have no traceable primary source. They get copied from one vendor page to the next, and the decimal points make them look like measurements when they are paraphrases of paraphrases. Layer on the fact that CJC-1295 is used loosely for two structurally different molecules, and you get published-looking numbers that disagree wildly. If a figure matters to a study design, take it from the indexed primary literature for that specific analogue and species. We would rather tell you the literature does not converge than hand you a decimal we cannot source.

Researchers comparing the two structures can review the individual listings for CJC-1295 No DAC and Ipamorelin, the CJC-1295 and Ipamorelin 5mg/5mg blend, and the Tesamorelin and Ipamorelin research stack used in comparative GHRH-analogue work. Background reference pages on CJC-1295 and Ipamorelin cover structure and reported research, every batch certificate of analysis is publicly viewable, and the wider research catalog includes related work such as peptides studied for immune system support.

How long does CJC-1295 Ipamorelin stay in your system turns out to be the wrong opening question. The right one is which CJC-1295 sits in the vial, because that one structural detail moves the answer from hours to weeks, and no amount of arithmetic fixes a wrong premise. Once DAC status is settled, the clearance math is simple and the literature is reassuringly consistent about the order of magnitude. What stays genuinely difficult is the part almost nobody asks about: the peptide leaves on a schedule you can calculate, and the endocrine signature it left behind leaves on a schedule you have to measure.